JPH06256137A - Beautifying dermatic external preparation - Google Patents

Beautifying dermatic external preparation

Info

Publication number
JPH06256137A
JPH06256137A JP5062530A JP6253093A JPH06256137A JP H06256137 A JPH06256137 A JP H06256137A JP 5062530 A JP5062530 A JP 5062530A JP 6253093 A JP6253093 A JP 6253093A JP H06256137 A JPH06256137 A JP H06256137A
Authority
JP
Japan
Prior art keywords
external preparation
ferulic acid
hair
formula
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5062530A
Other languages
Japanese (ja)
Inventor
Yoshikatsu Sayama
義克 佐山
Masayuki Kurosu
正之 黒須
Masataka Funayama
正孝 船山
Hirokuni Arakawa
博邦 荒川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Kurabo Industries Ltd
Kurashiki Spinning Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Kurabo Industries Ltd
Kurashiki Spinning Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd, Kurabo Industries Ltd, Kurashiki Spinning Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP5062530A priority Critical patent/JPH06256137A/en
Publication of JPH06256137A publication Critical patent/JPH06256137A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To provide an external preparation effective for eliminating pigmentation such as spots, also of extremely high safety. CONSTITUTION:The dermatic external preparation containing 0.00001-20 (pref. 0.0001-10)wt.% of ferulic acid compound (or a glycoside thereof) of the formula (R is H or pentose or hexose residue) which can be obtained by conifer blasting. Application of this external preparation suppresses the activity of tyrosinase, an oxidase, closely involved in melanization in the epidermal pigment cells and the hair, reducing the production of melanin, thus having improving effect for skin whitening and pigment elimination. The compound of the formula is most preferably nonglycosidated ferulic acid or ferulic DELTA-D-glucose in terms of beautifying effect, industrial convenience and safety etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はフェルラ酸またはその配
糖体を有効成分として含有する皮膚美白効果及び安全性
に優れた皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a skin external preparation which contains ferulic acid or a glycoside thereof as an active ingredient and is excellent in skin whitening effect and safety.

【0002】[0002]

【従来の技術】皮膚の色素沈着であるしみ、そばかすな
どの発生機序については不明な点が多いが、一般的には
紫外線の暴露やホルモン分泌の異常、メラニン代謝の異
常などが原因となって表皮でのメラニン色素産生が亢進
し、これが皮膚内に沈着するものと考えられている。
BACKGROUND OF THE INVENTION There are many unclear points about the mechanism of skin pigmentation such as stains and freckles, but it is generally caused by exposure to ultraviolet rays, abnormal hormone secretion, and abnormal melanin metabolism. It is believed that the production of melanin pigment in the epidermis is accelerated and deposited in the skin.

【0003】従来より、皮膚の色素沈着の軽減、防止に
対して様々な物質が応用されている。その1つに強力な
漂白作用を持つものとしてハイドロキノンが知られてい
るが、皮膚に対する作用が強力過ぎて永久的な色素脱出
を来す場合があるなど安全性の面で問題がある。近年で
は安全性に優れた皮膚美白用剤としてコウジ酸やアルブ
チンなどが開発応用されているが効果が緩徐で、長期間
連用しないと効果が得られにくいという問題があり、よ
り安全でしかも皮膚美白効果の高い治療方法が求められ
ている。
Conventionally, various substances have been applied to reduce or prevent skin pigmentation. Hydroquinone is known as one having a strong bleaching action, but there is a problem in terms of safety such that the action on the skin is too strong and permanent dye escape may occur. In recent years, kojic acid, arbutin, etc. have been developed and applied as highly safe skin whitening agents, but their effects are slow, and there is a problem that the effects are difficult to obtain unless they are used for a long period of time. A highly effective treatment method is required.

【0004】[0004]

【発明が解決しようとする課題】本発明はより安全でか
つ皮膚美白効果の高い新規皮膚外用剤を提供することを
目的とする。
DISCLOSURE OF THE INVENTION An object of the present invention is to provide a new skin external preparation which is safer and has a high skin whitening effect.

【0005】[0005]

【課題を解決するための手段】すなわち、本発明は下記
式(1)で示されるフェルラ酸またはその配糖体を含有
することを特徴とする安全性が高く皮膚美白効果の優れ
た皮膚外用剤である。
That is, the present invention comprises a highly safe and highly effective skin whitening agent characterized by containing ferulic acid represented by the following formula (1) or a glycoside thereof. Is.

【0006】[0006]

【化2】 〔式中Rは水素又は6単糖もしくは5単糖の残基を表わ
す〕。
[Chemical 2] [In the formula, R represents hydrogen or a residue of 6 monosaccharide or 5 monosaccharide].

【0007】上記(1)式でRがHであるフェルラ酸は
木材その他ほとんどすべての植物組織に含まれる天然有
機化合物であるリグニンの分解物として安価に得られる
物質である。そのリグニンの利用については、これまで
多くの試みがされているが、例えば、合成原料であるワ
ニリンをリグニンの酸化によって安価に製造して利用し
たり、また土壌改剤として利用されている。しかしこれ
らが代表的な利用方法であって他は工業的採算ベースに
のらないこともあり、天然界に多く存在するにもかかわ
らず、その利用については十分ではなく、ほとんどは燃
やされているのが現状である。ところが、本発明者は驚
くべきことに、針葉樹を爆砕処理することにより得られ
るフェルラ酸およびその配糖体がメラニン色素を生成さ
せる酸化酵素チロシナーゼの活性を阻害するという特性
を有することを究明し、本発明を完成したのである。
Ferulic acid in which R is H in the above formula (1) is a substance that can be obtained at a low cost as a decomposed product of lignin which is a natural organic compound contained in almost all plant tissues such as wood. Although many attempts have been made to use the lignin, for example, it is used as a synthetic raw material, vanillin, produced at low cost by oxidation of lignin, or used as a soil conditioner. However, since these are the typical usage methods and others are not on the industrial profit base, although there are many in the natural world, their usage is not sufficient and most of them are burned. is the current situation. However, the present inventors have surprisingly found that ferulic acid and its glycosides obtained by bombarding coniferous trees have the property of inhibiting the activity of the oxidative enzyme tyrosinase that produces melanin pigment, The present invention has been completed.

【0008】皮膚の色素沈着は紫外線・炎症等の刺激に
より亢進した表皮色素細胞でのメラニン色素産生が刺激
がなくなって亢進した状態のままにある現象と理解され
ている。メラニン色素の産生には色素細胞内におけるチ
ロシン酸化酵素(チロシナーゼ)が大きな役割を果たし
ている。
[0008] It is understood that skin pigmentation is a phenomenon in which melanin pigment production in epidermal pigment cells, which has been promoted by stimulation with ultraviolet rays, inflammation, etc., remains unstimulated and enhanced. Tyrosine oxidase (tyrosinase) in pigment cells plays a major role in the production of melanin pigment.

【0009】フェルラ酸およびその配糖体を有効成分と
して含有する皮膚外用剤を塗布することにより、表皮色
素細胞毛髪でのメラニン形成に大きくかかわる酸化酵素
チロシナーゼの活性を抑制させ、メラニン色素の産生を
減少させ、皮膚の白色化、色素沈着の改善に効果が得ら
れる。
By applying a skin external preparation containing ferulic acid and its glycoside as an active ingredient, the activity of the oxidative enzyme tyrosinase, which is greatly involved in the formation of melanin in epidermal pigment cell hair, is suppressed and the production of melanin pigment is suppressed. It is effective in reducing skin whitening and improving pigmentation.

【0010】本発明において上記一般式(1)で示され
るフェルラ酸またはフェルラ酸の配糖体が用いられる。
式中、Rは水素基又はD−グルコース、D−ガラクトー
ス、D−マンノース、D−タロース、D−フルクトー
ス、L−ガラクトース等の6単糖の残基、もしくはD−
アラビノース、D−キシロース、D−リボース、D−リ
ブロース、L−アラビノース、L−キシロース、L−リ
ボース、L−リブロース等の5単糖の残基を示すが、美
白効果、工業的利便性、安定性等の面から配糖化してい
ないフェルラ酸もしくはD−グルコースがβ結合したフ
ェルラ酸β−D−グルコースが最も好ましい。
In the present invention, ferulic acid or a glycoside of ferulic acid represented by the above general formula (1) is used.
In the formula, R is a hydrogen group or a residue of a hexasaccharide such as D-glucose, D-galactose, D-mannose, D-talose, D-fructose, L-galactose, or D-.
It shows residues of 5 monosaccharides such as arabinose, D-xylose, D-ribose, D-ribulose, L-arabinose, L-xylose, L-ribose and L-ribulose, but has a whitening effect, industrial convenience, and stability. From the viewpoint of properties, ferulic acid which is not glycosylated or β-D-glucose of ferulic acid to which β-bond of D-glucose is most preferable.

【0011】フェルラ酸およびその配糖体の配合量は剤
型などによって左右され、特に限定的ではないが、通常
は0.00001〜20重量%、好ましくは0.000
1〜10重量%であり、0.0001重量%未満の場合
には充分な皮膚の白色化、色素沈着の改善に効果が得難
い。
The amount of ferulic acid and its glycosides mixed depends on the dosage form and the like, and is not particularly limited, but is usually 0.00001 to 20% by weight, preferably 0.000.
The amount is 1 to 10% by weight, and if it is less than 0.0001% by weight, it is difficult to obtain sufficient effects of whitening the skin and improving pigmentation.

【0012】本発明の皮膚外用剤は、例えばヘアートニ
ック、ヘアートリートメント、ヘアークリーム、ヘアー
シャンプー、ヘアーリンスなどの毛髪化粧料に好適であ
り、その剤型は外用可能な任意の剤型であって良く、そ
の配合成分も化粧品、医薬部外品および医薬品などに常
用されている各種の成分、例えばアルコール等の溶剤お
よび溶解補助剤、界面活性剤、保湿剤、香料、着色剤、
防腐剤、粘度調整剤等を適宜配合することが出来る。
The external preparation for skin of the present invention is suitable for hair cosmetics such as hair nick, hair treatment, hair cream, hair shampoo, hair rinse, etc., and the dosage form is any externally applicable dosage form. Well, its ingredients are also various ingredients that are commonly used in cosmetics, quasi-drugs and pharmaceuticals, for example, solvents such as alcohol and solubilizers, surfactants, humectants, fragrances, colorants,
Preservatives, viscosity modifiers and the like can be added as appropriate.

【0013】[0013]

【作用】かくして得られる本発明の皮膚外用剤の有効性
および安全性などについての結果は次の通りである。
The effects and safety of the thus obtained external preparation for skin of the present invention are as follows.

【0014】(試験例) 試験例1:チロシナーゼの活性阻害試験 (1)チロシナーゼ粗酵素溶液の調製 B16 melanoma細胞を10%FCS,pen
icillin,streptomycin,amph
otericinB(Fungizon)を含むDul
becco´s modified eagles m
ediumにて、培養用シャーレ(φ9cm)あるいは
培養用フラスコ(75cm2 )を用いて37℃の条件下
で培養(95% air,5%CO2 )した。2〜3日
間培養して増殖した細胞を3分間Trypsin処理し
て浮遊させ、遠心分離(450×g,3分)して細胞を
集めた。得られた細胞を10mM生理食塩液加リン酸緩
衝液(pH6.8)で3回洗浄し、細胞数を計測した
後、0.1% tritonX−100を含む0.1M
リン酸緩衝液(pH6.8)に浮遊させた。浮遊液を氷
冷しながら超音波処理(15sec×3回)し、遠心分
離(11,000×g,20分,4℃)して上清を採取
した。得られた上清をチロシナーゼ粗酵素溶液とした。
Test Example Test Example 1: Tyrosinase activity inhibition test (1) Preparation of crude tyrosinase enzyme solution B16 melanoma cells were mixed with 10% FCS and pen.
icillin, streptomycin, amph
Dul including OtericinB (Funzizon)
becco's modified eggs m
In an edium, culture was performed (95% air, 5% CO 2 ) under the condition of 37 ° C using a culture dish (φ9 cm) or a culture flask (75 cm 2 ). The cells grown by culturing for 2 to 3 days were treated with Trypsin for 3 minutes to be suspended, and centrifuged (450 xg, 3 minutes) to collect the cells. The obtained cells were washed 3 times with a phosphate buffer (pH 6.8) containing 10 mM physiological saline, the number of cells was counted, and then 0.1 M containing 0.1% triton X-100 was added.
It was suspended in a phosphate buffer (pH 6.8). The suspension was sonicated (15 sec × 3 times) while cooling with ice, and centrifuged (11,000 × g, 20 minutes, 4 ° C.) to collect the supernatant. The resulting supernatant was used as a crude tyrosinase enzyme solution.

【0015】(2)チロシナーゼの活性に対するフェル
ラ酸およびその配糖体の作用 チロシナーゼの活性は秋保らの方法に準じて行った。即
ち、チロシナーゼ粗酵素溶液0.5mlとフェルラ酸お
よびその配糖体の50mMリン酸緩衝液(pH6.8,
以下これを緩衝液と略記する)0.1mlを混合し、更
に緩衝液0.9mlを加えて37℃で3分間加温した。
0.067%L−dopaを含む緩衝液0.5mlを加
えて37℃で475nmにおける吸光度の変化を経時的
に測定した。得られた吸光度変化の初速度よりチロシナ
ーゼ活性を算出し、下記式より阻害率を求めた。なお、
フェルラ酸およびその配糖体は緩衝液で0.1,1.
0,及び10mg/ml(最終濃度0.005,0.0
5,0.5mg/ml)に調製し、遠心分離(11,0
00×g,20分,4℃)した上清を反応系に添加し
た。又、式中フェルラ酸およびその配糖体は試験薬剤と
略記した。
(2) Action of ferulic acid and its glycoside on the activity of tyrosinase The activity of tyrosinase was determined according to the method of Akiu et al. That is, 0.5 ml of crude tyrosinase enzyme solution and 50 mM phosphate buffer solution of ferulic acid and its glycoside (pH 6.8,
Hereinafter, this is abbreviated as a buffer) 0.1 ml was mixed, 0.9 ml of the buffer was further added, and the mixture was heated at 37 ° C. for 3 minutes.
0.5 ml of a buffer solution containing 0.067% L-dopa was added, and the change in absorbance at 475 nm at 37 ° C. was measured over time. The tyrosinase activity was calculated from the obtained initial rate of change in absorbance, and the inhibition rate was calculated from the following formula. In addition,
Ferulic acid and its glycosides were buffered with 0.1, 1.
0, and 10 mg / ml (final concentration 0.005, 0.0
5, 0.5 mg / ml) and centrifuged (11,0
(00 × g, 20 minutes, 4 ° C.) was added to the reaction system. In the formula, ferulic acid and its glycoside are abbreviated as test agents.

【0016】[0016]

【数1】 結果を第1表に示すが、これにより本発明毛髪化粧料の
有効成分であるフェルラ酸およびその配糖体はメラニン
色素を生成させる酵素チロシナーゼの活性を阻害し、皮
膚の白色化に効果を示すことがわかる。
[Equation 1] The results are shown in Table 1. As a result, ferulic acid and its glycosides, which are the active ingredients of the hair cosmetic composition of the present invention, inhibit the activity of tyrosinase, an enzyme that produces melanin pigment, and have an effect on skin whitening. I understand.

【0017】[0017]

【表1】 [Table 1]

【0018】試験例2:皮膚感作試験(パッチテスト) 試 料:10%フェルラ酸およびその配糖体水溶液 実施方法:年齢20〜60才までの男性20名、女性2
0名計40名からなる被験者の上腕屈側部に試料および
対照溶液(生理食塩水)をそれぞれ浸漬したフィンチャ
ンバー用濾紙をフィンチャンバーのチャンバー部分に入
れ、貼付しクローズドパッチテストを実施した。貼付時
間は24時間とし、24時間後にフィンチャンバーを除
去し、試料除去後30分、及び24時間、48時間の3
回判定を行った。 判定基準: −:全く無反応 ±:軽微な紅斑 +:明らかな紅斑 ++:紅斑および腫脹または丘疹 +++:水疱を認めるもの 第2表に示すように本発明毛髪化粧料の有効成分のフェ
ルラ酸およびその配糖体は刺激反応およびアレルギー反
応を惹起する可能性は非常に少なく、安全性の高いこと
が明らかとなった。
Test Example 2: Skin sensitization test (patch test) Reagent: 10% ferulic acid and its glycoside aqueous solution Method of implementation: 20 males aged 20-60 years, 2 females
A fin chamber filter paper, in which a sample and a control solution (physiological saline) were respectively immersed in the flexed side of the upper arm of a subject consisting of 0 persons, was placed in the chamber portion of the fin chamber and affixed to the closed patch test. The application time was 24 hours, the fin chamber was removed after 24 hours, and 30 minutes after sample removal, and 3 hours of 24 hours and 48 hours.
Judgment was performed once. Criteria:-: No reaction ±: Slight erythema +: Clear erythema ++: Erythema and swelling or papules ++: Blisters are observed. As shown in Table 2, ferulic acid and the active ingredients of the hair cosmetic composition of the present invention It was revealed that the glycoside has a very low possibility of inducing irritation reaction and allergic reaction and is highly safe.

【0019】[0019]

【表2】 [Table 2]

【0020】[0020]

【実施例】以下に本発明の実施例を示す。尚、これら実
施例は本発明を何ら制限するものではない。
EXAMPLES Examples of the present invention will be shown below. Incidentally, these examples do not limit the present invention at all.

【0021】実施例1 〈ヘアートニック〉下記配合にて各成分を常法に従い金
属羽付液体混合機で混合撹拌しヘヤートニックを製造し
た。 フェルラ酸 0.5g ポリオキシエチレン(9)ラウリルエーテル 1.0g 1,3ブチレングリコール 5.0g エタノール 50.0g 香料 0.3g精製水 適量 全量100.0g
Example 1 <Hear tonic> A hair tonic was prepared by mixing and agitating each component in the following composition by a conventional liquid mixer with a metal blade. Ferulic acid 0.5 g Polyoxyethylene (9) lauryl ether 1.0 g 1,3 butylene glycol 5.0 g Ethanol 50.0 g Perfume 0.3 g Purified water Suitable amount Total 100.0 g

【0022】実施例2 〈ヘアートリートメント〉下記配合にて各成分を常法に
従い金属羽付液体混合機で混合撹拌しヘヤートリートメ
ントを製造した。 フェルラ酸β−D−グルコース 1.0g ポリオキシエチレン(10)ベヘニルエーテル 5.0g グリセリンモノステアレート 6.0g ミリスチン酸イソプロピル 5.0g ステアリン酸 5.0g 流動パラフィン 5.0g ラノリンアルコール 3.0g 1,3ブチレングリコール 5.0g トリエタノールアミン 1.0g メチルパラペン 0.1g エチルパラペン 0.1g 香料 0.3g精製水 適量 全量100.0g
Example 2 <Hair Treatment> Each component having the following composition was mixed and stirred by a liquid mixer with a metal blade according to a conventional method to produce a hair treatment. Ferulic acid β-D-glucose 1.0 g Polyoxyethylene (10) behenyl ether 5.0 g Glycerin monostearate 6.0 g Isopropyl myristate 5.0 g Stearic acid 5.0 g Liquid paraffin 5.0 g Lanolin alcohol 3.0 g 1 , 3 Butylene glycol 5.0 g Triethanolamine 1.0 g Methyl parapen 0.1 g Ethyl parapen 0.1 g Perfume 0.3 g Purified water Suitable amount Total 100.0 g

【0023】実施例3 〈ヘアークリーム〉下記配合にて各成分を常法に従い真
空乳化機で混合乳化して、ヘヤークリームを製造した。 フェルラ酸 1.0g 流動パラフィン 30.0g 脱水ラノリン 3.0g ミツロウ 2.0g セタノール 3.0g グリセリン 5.0g ポリオキシエチレン(10)セチルエーテル 3.0g ソルビタンモノステアレート 0.1g メチルパラペン 0.1g エチルパラペン 0.1g 香料 0.5g精製水 適量 全量100.0g
Example 3 <Hair Cream> A hair cream was produced by mixing and emulsifying each component in the following composition by a vacuum emulsifying machine according to a conventional method. Ferulic acid 1.0 g Liquid paraffin 30.0 g Dehydrated lanolin 3.0 g Beeswax 2.0 g Cetanol 3.0 g Glycerin 5.0 g Polyoxyethylene (10) cetyl ether 3.0 g Sorbitan monostearate 0.1 g Methyl parapen 0.1 g Ethyl Parapen 0.1g Perfume 0.5g Purified water Suitable amount Total 100.0g

【0024】実施例4 〈ヘアーシャンプー〉下記配合にて各成分を常法に従い
金属羽付液体混合機で混合撹拌してヘヤーシャンプーを
製造した。 フェルラ酸β−D−グルコース 0.5g ラウリル硫酸トリエタノールアミン 20.0g ラウリル硫酸ナトリウム 5.0g ステアリン酸マグネシウム 5.0g ラノリン 1.0g 1,3ブチレングリコール 5.0g セチルアルコール 2.0g ポリビニルアルコール 1.0g 香料 0.5g精製水 適量 全量100.0g
Example 4 <Hair shampoo> A hair shampoo was prepared by mixing and agitating each component in the following composition by a liquid mixer with a metal blade according to a conventional method. Ferulic acid β-D-glucose 0.5 g Lauryl sulfate triethanolamine 20.0 g Sodium lauryl sulfate 5.0 g Magnesium stearate 5.0 g Lanolin 1.0 g 1,3 Butylene glycol 5.0 g Cetyl alcohol 2.0 g Polyvinyl alcohol 1 0.0 g Fragrance 0.5 g Purified water Suitable amount Total 100.0 g

【0025】実施例5 〈ヘアーリンス〉下記配合にて各成分を常法に従い金属
羽付液体混合機で混合撹拌して、ヘアーリンスを製造し
た。 フェルラ酸 0.5g ポリオキシエチレン(2)オレイルエーテル 7.0g ジステアリルジメチルアンモニウムクロリド 3.0g プロピレングリコール 3.0g メチルパラペン 0.1g エチルパラペン 0.1g 香料 0.3g精製水 適量 全量100.0g
Example 5 <Hair Rinse> The following components were mixed and stirred in a liquid mixer with a metal blade according to a conventional method to produce a hair rinse. Ferulic acid 0.5 g Polyoxyethylene (2) oleyl ether 7.0 g Distearyldimethylammonium chloride 3.0 g Propylene glycol 3.0 g Methyl parapen 0.1 g Ethyl parapen 0.1 g Perfume 0.3 g Purified water Total amount 100.0 g

【0026】[0026]

【発明の効果】本発明の美白皮膚外用剤は、しみなどの
皮膚の色素沈着を白色化するのに有効であり、かつ極め
て安全性も高いという効果を有する。
Industrial Applicability The whitening skin external preparation of the present invention is effective in whitening skin pigmentation such as spots, and is extremely safe.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 船山 正孝 大阪府寝屋川市下木田町14−5 倉敷紡績 株式会社技術研究所内 (72)発明者 荒川 博邦 大阪府寝屋川市下木田町14−5 倉敷紡績 株式会社技術研究所内 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Masataka Funayama 14-5 Shimokita Town, Neyagawa City, Osaka Prefecture Kurashiki Spinning Co., Ltd. Technical Research Institute (72) Hirokuni Arakawa 14-5 Shimokita Town, Neyagawa City, Osaka Spinner Kurashiki Technical Research Institute Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 下記式(1)で示されるフェルラ酸また
はその配糖体を含有することを特徴とする皮膚外用剤。 【化1】 〔式中Rは水素又は6単糖もしくは5単糖の残基を表わ
す〕
1. An external preparation for skin comprising ferulic acid represented by the following formula (1) or a glycoside thereof. [Chemical 1] [In the formula, R represents hydrogen or a residue of 6 monosaccharide or 5 monosaccharide]
JP5062530A 1993-03-01 1993-03-01 Beautifying dermatic external preparation Pending JPH06256137A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5062530A JPH06256137A (en) 1993-03-01 1993-03-01 Beautifying dermatic external preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5062530A JPH06256137A (en) 1993-03-01 1993-03-01 Beautifying dermatic external preparation

Publications (1)

Publication Number Publication Date
JPH06256137A true JPH06256137A (en) 1994-09-13

Family

ID=13202852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5062530A Pending JPH06256137A (en) 1993-03-01 1993-03-01 Beautifying dermatic external preparation

Country Status (1)

Country Link
JP (1) JPH06256137A (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258042A (en) * 1994-03-15 1995-10-09 Sanwa Shiyouyaku Kk Novel hair restoration and growth stimulant
DE19615575A1 (en) * 1996-04-19 1997-10-23 Beiersdorf Ag Use of glucosides and ferulic acid as an anti-irritative agent in cosmetic and topical dermatological preparations
JPH10147514A (en) * 1996-11-19 1998-06-02 Pola Chem Ind Inc Cosmetic
WO1999003446A3 (en) * 1997-07-17 1999-08-12 E L Management Corp Antimicrobial cosmetic compositions
JP2003521505A (en) * 2000-02-07 2003-07-15 コグニス・フランス・ソシエテ・アノニム Cosmetic formulation containing Waltheria indica extract
JP2010037251A (en) * 2008-08-04 2010-02-18 Ezaki Glico Co Ltd Skin external preparation
EP2241303A3 (en) * 2009-04-02 2015-09-02 Sesvalia USA, LLC Systems and methods for skin rejuvenation
JP2017517581A (en) * 2014-06-17 2017-06-29 ザ プロクター アンド ギャンブル カンパニー Composition for reducing hair curling
US10111820B2 (en) 2014-12-05 2018-10-30 The Procter And Gamble Company Composition for hair frizz reduction
US10117819B2 (en) 2014-12-05 2018-11-06 The Procter And Gamble Company Composition for hair frizz reduction
US10258555B2 (en) 2015-12-04 2019-04-16 The Procter And Gamble Company Composition for hair frizz reduction
US10406094B2 (en) 2016-04-01 2019-09-10 The Procter And Gamble Company Composition for fast dry of hair
US10561591B2 (en) 2015-12-04 2020-02-18 The Procter And Gamble Company Hair care regimen using compositions comprising moisture control materials
US10632054B2 (en) 2015-04-02 2020-04-28 The Procter And Gamble Company Method for hair frizz reduction
US10660835B2 (en) 2015-04-02 2020-05-26 The Procter And Gamble Company Method for hair frizz reduction
US10980723B2 (en) 2017-04-10 2021-04-20 The Procter And Gamble Company Non-aqueous composition for hair frizz reduction

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61207317A (en) * 1985-03-13 1986-09-13 Shiseido Co Ltd External agent for skin
JPS6289608A (en) * 1985-10-16 1987-04-24 Shiseido Co Ltd External preparation for skin
JPS6413016A (en) * 1987-07-03 1989-01-17 Pola Chem Ind Inc Skin external preparation
JPH02229102A (en) * 1989-03-03 1990-09-11 Lion Corp Skin drug for external use
JPH041115A (en) * 1990-04-13 1992-01-06 Pola Chem Ind Inc Dermal drug for external use
JPH041116A (en) * 1990-04-16 1992-01-06 Pola Chem Ind Inc Dermal drug for external use
JPH0459718A (en) * 1990-06-28 1992-02-26 Pola Chem Ind Inc External preparation of skin
JPH04266807A (en) * 1991-02-22 1992-09-22 Soken:Kk Skin improver
JPH05255037A (en) * 1992-03-13 1993-10-05 Eisai Co Ltd Ferulic acid-containing cosmetic
JPH05310526A (en) * 1992-05-07 1993-11-22 Eisai Co Ltd Cell differentiation promotor

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61207317A (en) * 1985-03-13 1986-09-13 Shiseido Co Ltd External agent for skin
JPS6289608A (en) * 1985-10-16 1987-04-24 Shiseido Co Ltd External preparation for skin
JPS6413016A (en) * 1987-07-03 1989-01-17 Pola Chem Ind Inc Skin external preparation
JPH02229102A (en) * 1989-03-03 1990-09-11 Lion Corp Skin drug for external use
JPH041115A (en) * 1990-04-13 1992-01-06 Pola Chem Ind Inc Dermal drug for external use
JPH041116A (en) * 1990-04-16 1992-01-06 Pola Chem Ind Inc Dermal drug for external use
JPH0459718A (en) * 1990-06-28 1992-02-26 Pola Chem Ind Inc External preparation of skin
JPH04266807A (en) * 1991-02-22 1992-09-22 Soken:Kk Skin improver
JPH05255037A (en) * 1992-03-13 1993-10-05 Eisai Co Ltd Ferulic acid-containing cosmetic
JPH05310526A (en) * 1992-05-07 1993-11-22 Eisai Co Ltd Cell differentiation promotor

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258042A (en) * 1994-03-15 1995-10-09 Sanwa Shiyouyaku Kk Novel hair restoration and growth stimulant
DE19615575A1 (en) * 1996-04-19 1997-10-23 Beiersdorf Ag Use of glucosides and ferulic acid as an anti-irritative agent in cosmetic and topical dermatological preparations
EP0801945A3 (en) * 1996-04-19 2001-11-28 Beiersdorf Aktiengesellschaft Use of ferulic acid glucosides as agents against irritation in cosmetic or topical dermatological compositions
JPH10147514A (en) * 1996-11-19 1998-06-02 Pola Chem Ind Inc Cosmetic
WO1999003446A3 (en) * 1997-07-17 1999-08-12 E L Management Corp Antimicrobial cosmetic compositions
US6114377A (en) * 1997-07-17 2000-09-05 E-L Management Corp. Antimicrobial cosmetic compositions
US6387947B1 (en) 1997-07-17 2002-05-14 E-L Management Corp. Antimicrobial cosmetic compositions
KR100757281B1 (en) * 1997-07-17 2007-09-11 이-엘 매니지먼트 코포레이션 Novel antimicrobial cosmetic compositions
KR100771460B1 (en) * 1997-07-17 2007-10-31 이-엘 매니지먼트 코포레이션 Novel antimicrobial cosmetic compositions
JP2003521505A (en) * 2000-02-07 2003-07-15 コグニス・フランス・ソシエテ・アノニム Cosmetic formulation containing Waltheria indica extract
JP2010037251A (en) * 2008-08-04 2010-02-18 Ezaki Glico Co Ltd Skin external preparation
EP2241303A3 (en) * 2009-04-02 2015-09-02 Sesvalia USA, LLC Systems and methods for skin rejuvenation
US9241887B2 (en) 2009-04-02 2016-01-26 Sesvalia Usa, Llc Systems and methods for skin rejuvenation
JP2017517581A (en) * 2014-06-17 2017-06-29 ザ プロクター アンド ギャンブル カンパニー Composition for reducing hair curling
US10111815B2 (en) 2014-06-17 2018-10-30 The Procter And Gamble Company Composition for hair frizz reduction
US10111820B2 (en) 2014-12-05 2018-10-30 The Procter And Gamble Company Composition for hair frizz reduction
US10117819B2 (en) 2014-12-05 2018-11-06 The Procter And Gamble Company Composition for hair frizz reduction
US10632054B2 (en) 2015-04-02 2020-04-28 The Procter And Gamble Company Method for hair frizz reduction
US10660835B2 (en) 2015-04-02 2020-05-26 The Procter And Gamble Company Method for hair frizz reduction
US10258555B2 (en) 2015-12-04 2019-04-16 The Procter And Gamble Company Composition for hair frizz reduction
US10561591B2 (en) 2015-12-04 2020-02-18 The Procter And Gamble Company Hair care regimen using compositions comprising moisture control materials
US10406094B2 (en) 2016-04-01 2019-09-10 The Procter And Gamble Company Composition for fast dry of hair
US10980723B2 (en) 2017-04-10 2021-04-20 The Procter And Gamble Company Non-aqueous composition for hair frizz reduction

Similar Documents

Publication Publication Date Title
CA1069046A (en) Tar gel formulation
JPH06256137A (en) Beautifying dermatic external preparation
KR101339096B1 (en) Skin lightening composition for hyperpigmented skin
DE3336760A1 (en) Mild CLEANING COMPOSITION
JPH1192334A (en) Cosmetic composition especially useful for whitening of skin and melanogenesis-suppressing agent containing the same cosmetic composition
JPH07316034A (en) Method of using resorcinol derivative mono-or di-substitutedat 4,4-and 5-,or 4-and 6-positions for cosmetic composition or dermal medicinal composition having depigmentation action
EP0854700B1 (en) Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss
EP0484199B1 (en) Cosmetic use of an anti-erythema composition
JPH03236322A (en) Skin drug for external use
JP3557095B2 (en) Melanin production inhibitor
JP4067073B2 (en) Skin cosmetics
FR2891737A1 (en) Use of C-glycoside compounds in a regime or regimen for de-pigmentation or whitening of skin
FR2886297A1 (en) New C-glycoside compounds are tyrosinase inhibitors used in depigmenting and/or bleaching skin or hair
JP3480954B2 (en) External preparation for skin
KR100472919B1 (en) Water soluble whitening composition and cosmetic composition for whitening skin comprising the same
JPH1029922A (en) Preparation for external use for skin
JP4537545B2 (en) Cosmetics
JPH06256138A (en) Beautifying dermatic external preparation
JP4346231B2 (en) Cosmetics
JP3120087B2 (en) Hair cosmetics for prevention of gray hair and blackening of gray hair
JP2001122792A (en) Skin preparation for external use
JPH092967A (en) Tyrosinase activity inhibitor and cosmetic containing the same
JP3233504B2 (en) Cosmetics
JP2002308753A (en) Elastase activity inhibitor, estrogenic activator and anti- aging agent for skin containing the same inhibitor or the same activator
JPH069366A (en) External agent for skin